22 Aug 2025
🧪FDA Guidance on Information Collection for Influenza A Reagents
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance on Reagents for Detection of Specific Novel Influenza A Viruses
Summary
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$$ - High
The content discusses FDA's guidance on information collection regarding reagents for detecting novel influenza A viruses, which is critical for businesses involved in medical diagnostics and healthcare compliance, thus impacting regulatory responsibilities and operational practices.